{"id":"W2110991424","doi":"10.1016/j.juro.2012.10.017","title":"Results of a Randomized Phase III Trial of Mirabegron in Patients with Overactive Bladder","year":2012,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":368,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Astellas Pharma","keywords":"Mirabegron; Overactive bladder; Medicine; Placebo; Adverse effect; Urology; Urination; Randomized controlled trial; Urinary incontinence; Urinary system; Internal medicine; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003364915,0.00007914966,0.0007587997,0.0001988447,0.00001375511,9.907202e-7,0.00008999053,0.00005839039,0.00007268549],"category_scores_gemma":[0.0005788493,0.00003839603,0.0001038206,0.0001300523,0.0002273479,0.00009806787,0.00002520665,0.000383789,0.00000112891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001754035,"about_ca_system_score_gemma":0.000127503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004851826,"about_ca_topic_score_gemma":0.000002333465,"domain_scores_codex":[0.9977823,0.0008928921,0.0007073694,0.00004749979,0.0003661155,0.0002037883],"domain_scores_gemma":[0.9976223,0.001215599,0.0006563464,0.0001473664,0.0002807191,0.00007765401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9909067,0.002647184,0.00141184,0.00001233715,0.0004373952,0.000009313117,0.002847452,0.000008611148,0.0005854365,0.00001083396,0.0002034882,0.0009194182],"study_design_scores_gemma":[0.970912,0.01815983,0.008926525,0.00002346532,0.0004186364,0.00006058286,0.0001203888,0.00001833733,0.001048866,0.00007409866,0.0002025997,0.00003469476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968626,0.0004264248,0.00003798378,0.0007582727,0.0001009763,0.0007150802,0.000008401043,9.611548e-7,0.001089288],"genre_scores_gemma":[0.9995232,0.0001837818,0.00004806831,0.00005350166,0.0001198448,0.000002586113,0.00000354844,0.000007568351,0.00005790255],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01999471,"threshold_uncertainty_score":0.1667393,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02180478165129066,"score_gpt":0.3304379304377846,"score_spread":0.3086331487864939,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}